What is KPV peptide research guide showing KPV tripeptide structure

What Is KPV? Complete Research Guide (2026)

KPV is a short tripeptide consisting of three amino acids: lysine, proline, and valine. It corresponds to the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH), a peptide derived from the proopiomelanocortin (POMC) precursor. KPV has attracted scientific interest because research suggests that this small peptide sequence retains several of the inflammatory-signaling properties associated with α-MSH without containing the complete melanocortin receptor-binding sequence of the parent hormone.

Research on KPV has primarily focused on inflammatory signaling, epithelial biology, gastrointestinal research, and cellular responses. Experimental studies have investigated pathways including NF-κB signaling and PepT1-mediated cellular uptake, while other research has examined KPV in models of inflammation. However, the available evidence is predominantly preclinical, and findings from cell and animal studies should not be interpreted as established human therapeutic outcomes. Read the foundational KPV anti-inflammatory study on PubMed.

Quick Answer

KPV is a three-amino-acid peptide composed of lysine, proline, and valine. It is the C-terminal tripeptide sequence of α-MSH and has been investigated primarily in preclinical research involving inflammatory signaling, epithelial biology, gastrointestinal models, and cellular pathways such as NF-κB. KPV is a research compound rather than an approved human therapy.

Table of Contents

What Is KPV?

KPV is a tripeptide composed of the amino acids lysine (K), proline (P), and valine (V). Its sequence is therefore abbreviated as Lys-Pro-Val. KPV represents the C-terminal portion of α-MSH and has been investigated as an independent peptide sequence in experimental research.

The significance of KPV comes largely from its relationship to α-MSH. α-MSH is a melanocortin peptide involved in several biological processes, including pigmentation and immune regulation. Research dating back several decades has identified anti-inflammatory activity associated with α-MSH, with studies suggesting that much of this activity can be attributed to its C-terminal KPV sequence. Read the review of α-MSH-related peptides on PMC.

Unlike full-length α-MSH, KPV is extremely small and lacks the complete sequence required for conventional binding to known melanocortin receptors. This distinction has made KPV particularly interesting to researchers investigating whether biological activity associated with α-MSH can be separated from the hormone's broader melanocortin activity.

Research has consequently examined KPV in several experimental systems, including immune cells, intestinal epithelial cells, airway epithelial cells, and animal models of inflammation. These studies have produced evidence of interactions with inflammatory signaling pathways, although the precise mechanisms remain an active area of investigation.

What Does KPV Stand For?

The name KPV comes directly from the three amino acids that make up the peptide:

  • K — Lysine
  • P — Proline
  • V — Valine

Because it contains only three amino acids, KPV is substantially smaller than many research peptides. This makes it useful for studying the biological activity of a defined peptide sequence rather than the activity of an entire precursor or larger hormone.

Research Insight

KPV is not a shortened version of α-MSH created simply for convenience. It is a defined three-amino-acid sequence—Lys-Pro-Val—that occurs at the C-terminal end of α-MSH and has been independently investigated for biological activity.

Where Does KPV Come From?

KPV originates from the C-terminal region of alpha-melanocyte-stimulating hormone (α-MSH). α-MSH itself is generated from the larger proopiomelanocortin (POMC) precursor through post-translational processing. POMC-derived peptides participate in several physiological signaling systems, including melanocortin pathways.

α-MSH became known initially for its role in melanocyte biology and pigmentation. Subsequent research demonstrated that melanocortin peptides also influence immune and inflammatory processes. Reviews of the literature describe α-MSH as an endogenous modulator of inflammatory signaling, including pathways involving cytokines, adhesion molecules, chemokines, and NF-κB. Review the α-MSH inflammatory literature on PubMed.

Researchers subsequently investigated individual regions of α-MSH to determine which sequences were responsible for particular biological effects. This work identified the C-terminal KPV sequence as an important component of the peptide's experimental anti-inflammatory activity.

Why Was KPV Studied Separately From α-MSH?

One reason is mechanistic separation. Full-length α-MSH interacts with melanocortin receptors and has multiple biological activities. KPV lacks the complete receptor-binding sequence associated with the classical melanocortin pharmacophore, yet experimental studies have found that it can retain anti-inflammatory activity.

A 2010 review noted that KPV lacks the sequence motif required for binding to known melanocortin receptors while retaining much of the anti-inflammatory activity observed with α-MSH. The authors also emphasized that the precise signaling mechanism used by KPV remained unresolved. Read the review on α-MSH-related peptides on PubMed.

This makes KPV useful as a research tool because investigators can study the effects of a very small peptide sequence independently of the complete α-MSH molecule.

KPV Structure and Characteristics

KPV consists of only three amino acids: Lys-Pro-Val. Its small molecular structure distinguishes it from longer peptides such as BPC-157, which contains 15 amino acids, or larger peptide hormones and analogues containing several dozen amino acids.

The sequence of a peptide is fundamental to its biological behavior. Even relatively small changes in amino acid sequence can alter molecular interactions, transport, stability, receptor binding, and downstream signaling. KPV therefore provides researchers with a particularly simple model for studying sequence-specific peptide activity.

KPV at a Glance

Characteristic Description
Name KPV
Sequence Lys-Pro-Val
Peptide Type Tripeptide
Parent Peptide α-Melanocyte-stimulating hormone (α-MSH)
Primary Research Areas Inflammatory signaling, epithelial biology, gastrointestinal research, cellular signaling
Evidence Base Predominantly preclinical

Why KPV's Small Size Matters

Short peptides can provide researchers with a way to investigate the activity of specific sequence motifs without the structural complexity of a larger protein or peptide hormone. KPV is particularly interesting in this respect because its three-amino-acid sequence is associated with biological activity observed in studies of the much larger α-MSH molecule.

Research on KPV has also demonstrated that small peptides can interact with cellular transport systems. For example, studies of intestinal inflammation have investigated uptake of KPV through peptide transporter 1 (PepT1), a transporter capable of moving certain di- and tripeptides into cells. View the KPV and PepT1 study on PubMed.

KPV and α-MSH: What's the Connection?

The connection between KPV and α-MSH is central to understanding why this small tripeptide has attracted research interest. α-MSH is a 13-amino-acid melanocortin peptide derived from POMC. KPV represents its C-terminal three-amino-acid sequence.

Research investigating α-MSH demonstrated that the hormone possesses significant anti-inflammatory activity in addition to its better-known melanocortin effects. Researchers subsequently examined shorter peptide fragments to determine which regions were responsible for specific biological actions.

Experimental evidence identified KPV as an important component of α-MSH's inflammatory signaling profile. A review published in Annals of the Rheumatic Diseases describes the C-terminal KPV sequence as responsible for much of the anti-inflammatory activity attributed to α-MSH-related peptides. Read the full review on PMC.

KPV vs α-MSH

Characteristic KPV α-MSH
Length 3 amino acids 13 amino acids
Sequence Lys-Pro-Val Full α-MSH sequence
Relationship C-terminal sequence of α-MSH Parent melanocortin peptide
Research Focus Inflammatory and cellular signaling Melanocortin, pigmentation, immune and inflammatory signaling
Melanocortin Receptor Binding Lacks the complete classical receptor-binding motif Interacts with melanocortin receptors

The distinction matters because KPV should not simply be described as “α-MSH.” It is a separate, much smaller peptide sequence derived from the parent molecule and studied for biological properties that may occur through mechanisms different from classical melanocortin receptor activation.

Key Takeaway

KPV is the C-terminal Lys-Pro-Val sequence of α-MSH. Although it is derived from α-MSH, research suggests that KPV can exhibit biological activity through mechanisms that differ from the classical melanocortin receptor signaling associated with the full-length hormone.

How Does KPV Work?

The exact mechanism of action of KPV remains an active area of research. Unlike α-MSH, which has well-characterized interactions with melanocortin receptors, KPV does not contain the complete sequence generally required for classical melanocortin receptor activation. Researchers have therefore investigated alternative mechanisms that may explain its biological activity.

The strongest areas of mechanistic research involve NF-κB signaling, inflammatory mediator regulation, and peptide transport through PepT1. These pathways are particularly relevant because they connect KPV research to cellular inflammation and epithelial biology. However, the available evidence should be interpreted primarily as preclinical research rather than as an established human mechanism.

NF-κB Signaling

Nuclear factor kappa B, commonly abbreviated as NF-κB, is a family of transcription factors involved in regulating numerous genes associated with immune and inflammatory responses. Activation of NF-κB can increase the expression of inflammatory mediators, adhesion molecules, chemokines, and other signaling proteins.

KPV has been investigated for its ability to influence NF-κB-related signaling. In experimental studies, researchers have observed reduced inflammatory signaling following exposure to KPV, providing one possible explanation for the biological activity associated with the peptide.

A foundational study published in Peptides investigated the effects of KPV and related α-MSH-derived peptides on NF-κB activation and inflammatory responses. Read the KPV NF-κB study on PubMed.

Importantly, inhibition of an inflammatory signaling pathway in an experimental model does not automatically establish a therapeutic effect in humans. The findings instead provide a mechanistic basis for further investigation.

Inflammatory Mediator Regulation

Research involving KPV has also examined inflammatory mediators produced by activated immune and epithelial cells. These mediators can include cytokines, chemokines, and other signaling molecules that coordinate cellular responses to environmental or biological stimuli.

The experimental literature suggests that KPV can influence aspects of this inflammatory signaling network. This is one reason the peptide has been investigated in models involving intestinal inflammation, epithelial cells, and other systems in which inflammatory signaling is a central research endpoint.

PepT1-Mediated Cellular Uptake

One of the more unusual aspects of KPV research is its relationship with peptide transporter 1 (PepT1). PepT1 is a membrane transporter involved in the uptake of small peptides and peptide-like compounds, particularly in the intestinal tract.

Researchers have investigated whether KPV can utilize PepT1 to enter intestinal epithelial cells. This work is important because it provides a potential explanation for how a very small peptide sequence can interact with epithelial cells and influence intracellular signaling.

Experimental intestinal research has reported that KPV can be transported through PepT1 and that this transport is associated with changes in inflammatory signaling. View the PepT1 and KPV research on PubMed.

Research Insight

KPV's research profile is unusual because its biological activity appears not to depend solely on classical melanocortin receptor signaling. Research has instead examined mechanisms involving NF-κB regulation, inflammatory mediator expression, and PepT1-mediated cellular transport.

KPV and Inflammatory Signaling Research

Inflammatory signaling is one of the most extensively investigated areas of KPV research. The interest originated partly from studies showing that α-MSH can regulate inflammatory responses and that the C-terminal KPV sequence accounts for a substantial portion of this activity.

Researchers have subsequently investigated KPV directly in cellular and animal models to determine whether the tripeptide can influence inflammatory pathways independently of full-length α-MSH.

NF-κB and Inflammatory Gene Expression

NF-κB serves as an important regulatory system for genes involved in inflammation. When activated, NF-κB can move into the cell nucleus and influence transcription of inflammatory mediators.

Experimental studies involving KPV have reported modulation of NF-κB activity. This has led researchers to investigate KPV as a tool for examining how short peptide sequences can influence inflammatory gene-expression pathways.

The importance of this research is not that KPV has been proven to treat inflammation, but that it provides a defined molecular probe for studying the relationship between peptide signaling and inflammatory transcription pathways.

KPV and Cytokine Research

Cytokines are signaling proteins involved in communication between immune and other cells. Research into KPV has examined cytokine-related responses in several experimental systems.

The effects observed in these studies vary according to the model, cell type, inflammatory stimulus, and experimental conditions. This variability reinforces the importance of interpreting KPV research within the context of the specific experimental system rather than assuming that one finding applies universally.

KPV and Immune-Cell Research

Earlier research into α-MSH-derived peptides demonstrated that KPV can influence inflammatory responses in immune-cell models. These studies helped establish the foundation for later investigations into KPV's effects on inflammatory signaling.

For researchers interested in the broader relationship between melanocortin peptides and immune regulation, the scientific literature provides useful context on how α-MSH-derived sequences interact with inflammatory pathways. Review the α-MSH and inflammation literature on PMC.

KPV and Gastrointestinal Research

The gastrointestinal tract is one of the most important areas of KPV research because intestinal epithelial cells express peptide transporter 1 (PepT1). This transporter provides a mechanism through which small peptide sequences can interact with intestinal cells.

Researchers have investigated KPV in experimental models involving intestinal inflammation, epithelial signaling, and inflammatory mediator production. These studies have helped establish the gastrointestinal tract as an important model system for understanding KPV biology.

PepT1 and Intestinal Epithelial Cells

PepT1 is primarily known for transporting small dietary peptides across the intestinal epithelium. Research has shown that the transporter can also participate in the uptake of certain peptide-based compounds.

Studies involving KPV have investigated PepT1-dependent uptake as a potential mechanism for delivering the tripeptide into intestinal epithelial cells. Once inside the cell, KPV may interact with intracellular signaling systems associated with inflammatory responses.

This provides an important mechanistic link between the peptide's small size and its experimental activity in gastrointestinal models. See the published KPV-PepT1 research on PubMed.

Intestinal Inflammation Models

Experimental research has examined KPV in models of intestinal inflammation, including studies investigating inflammatory mediator production and epithelial responses.

These models are particularly useful for studying how peptide transport, epithelial signaling, and immune responses interact within the gastrointestinal environment. They do not, however, establish KPV as a clinically validated treatment for gastrointestinal disease.

Why Gastrointestinal Research Matters

The gastrointestinal tract represents a complex biological environment where epithelial cells, immune cells, microorganisms, and signaling molecules interact continuously. A short peptide such as KPV provides researchers with a relatively simple tool for investigating specific components of this network.

The combination of PepT1-mediated uptake and inflammatory signaling is therefore one of the more distinctive aspects of KPV research compared with many other short research peptides.

Key Takeaway

Gastrointestinal research is an important part of the KPV literature. Studies have investigated how KPV interacts with intestinal epithelial cells, including research into PepT1-mediated uptake and downstream inflammatory signaling.

KPV and Epithelial Research

Epithelial cells form protective barriers throughout the body, including the gastrointestinal tract, respiratory system, and skin. Because these tissues must constantly balance barrier function with inflammatory responses, epithelial biology provides an important setting for investigating KPV.

Research has examined KPV in epithelial-cell models to investigate interactions between peptide transport, inflammatory signaling, and cellular responses. These studies complement the gastrointestinal literature and broaden the potential research applications of the peptide.

Barrier Biology

Epithelial barriers regulate what enters and leaves tissues while also participating actively in immune signaling. When epithelial cells encounter inflammatory stimuli, they can produce cytokines, chemokines, and other signaling molecules.

KPV research has investigated whether the peptide can modify these cellular responses. This makes it relevant to experimental studies examining the intersection between epithelial function and inflammation.

Skin and Epithelial Models

The relationship between KPV and epithelial biology has also generated interest in skin-related research. Skin is an epithelial organ with complex interactions between keratinocytes, immune cells, connective tissue, and signaling molecules.

Researchers studying KPV in this context are primarily interested in cellular signaling and inflammatory pathways rather than treating a specific dermatological condition. This distinction is important when translating findings from experimental models into broader educational content.

For a broader look at peptides studied in skin and tissue biology, see our Best Peptides for Anti-Aging & Longevity Research guide and our research on GHK-Cu.

What Does the Scientific Evidence Show?

The scientific literature on KPV is promising from a preclinical research perspective, but it is important to distinguish mechanistic findings from clinical evidence. Much of the published work has been conducted using cultured cells, isolated tissues, or animal models rather than controlled human trials.

Early research established a connection between the C-terminal KPV sequence of α-MSH and the parent peptide's anti-inflammatory activity. Subsequent studies investigated KPV independently, including its effects on inflammatory signaling and its transport into intestinal epithelial cells. These studies provide a biological rationale for continued investigation, but they do not establish KPV as a clinically proven treatment.

Cellular Research

Cell-based studies are particularly useful for investigating KPV because they allow researchers to isolate specific molecular pathways. Experiments have examined KPV's effects on NF-κB activity, inflammatory mediator production, and peptide transport.

These studies can help identify potential molecular mechanisms before compounds are evaluated in more complex biological models. However, cell culture systems lack many of the physiological variables present in living organisms, meaning that findings cannot automatically be extrapolated to humans.

Animal Research

Animal studies have expanded the KPV literature into more complex models of inflammation and epithelial biology. These experiments can provide information about interactions between multiple tissues and biological systems that cannot be reproduced in isolated cells.

The animal literature remains important for generating hypotheses and evaluating biological mechanisms, but species differences in metabolism, transport, immune function, and peptide activity mean that animal findings require additional validation before conclusions can be drawn about humans.

Human Evidence

Compared with the extensive mechanistic and preclinical literature, human clinical evidence for KPV is limited. There is currently insufficient clinical evidence to establish KPV as an approved treatment or to determine therapeutic efficacy in humans.

This distinction is especially important because online discussions about KPV can sometimes present experimental findings as established human outcomes. A research peptide can have an interesting biological mechanism without having demonstrated clinical safety or efficacy.

Evidence Summary

The strongest evidence for KPV currently comes from cellular and preclinical research. Studies provide mechanistic evidence involving inflammatory signaling, epithelial biology, and peptide transport, but substantially more human research would be required to establish clinical safety and efficacy.

How Is KPV Used in Research?

KPV can serve as a research tool in experiments designed to investigate the relationship between short peptide sequences and cellular signaling. Because the molecule is only three amino acids long, it provides a relatively simple system for examining sequence-specific biological activity.

Researchers may investigate KPV in several different experimental contexts depending on the question being studied. The most established areas include inflammatory signaling, epithelial biology, gastrointestinal research, and α-MSH-derived peptide research.

Inflammatory Pathway Research

KPV can be investigated in cellular models where researchers activate inflammatory signaling pathways and measure downstream responses. Endpoints may include NF-κB activity, cytokine expression, chemokine production, or other molecular markers of cellular signaling.

These experiments can help researchers determine whether KPV influences specific molecular pathways and whether those effects depend on particular cell types or inflammatory stimuli.

Gastrointestinal Biology

Because intestinal epithelial cells express PepT1, KPV provides a useful research model for studying how small peptides interact with intestinal transport systems.

Researchers can investigate peptide uptake, intracellular signaling, epithelial responses, and interactions between peptide transport and inflammatory pathways. The published PepT1 literature provides an important foundation for this research area. View the relevant study on PubMed.

α-MSH-Derived Peptide Research

KPV can also be used as a simplified model for investigating the biological activity of α-MSH-derived sequences. Comparing KPV with full-length α-MSH and other peptide fragments can help researchers determine which portions of larger peptide molecules are responsible for particular cellular effects.

This approach is useful in structure–activity relationship research, where researchers systematically examine how peptide sequence relates to biological activity.

Comparative Peptide Research

KPV can also be studied alongside other research peptides when investigators want to compare different biological mechanisms. For example, BPC-157 has a substantially different research profile centered on vascular and tissue biology, while GHK-Cu is extensively investigated in extracellular-matrix and skin research.

This type of comparison can help researchers distinguish whether observed experimental responses are associated with inflammatory signaling, cellular migration, matrix remodeling, or other mechanisms.

What to Look for When Sourcing KPV

For laboratory research, selecting a peptide involves more than looking at the name and stated quantity on a product page. Purity, identity, batch documentation, and storage conditions can all affect the reproducibility of an experiment.

HPLC Purity

High-performance liquid chromatography (HPLC) is commonly used to evaluate the chemical purity of synthetic peptides. A batch-specific HPLC result can provide researchers with information about the proportion of the sample associated with the intended peptide relative to detectable impurities.

A stated purity percentage is more useful when it is supported by documentation corresponding to the specific batch being supplied.

Mass-Spectrometry Identity

Mass spectrometry provides a different form of analytical information. While HPLC is primarily used to assess purity, mass spectrometry can help confirm that the molecular mass is consistent with the intended peptide.

For research materials, having both purity and identity information provides a more complete picture of the material being evaluated.

Batch-Specific COA

A Certificate of Analysis (COA) should ideally correspond to the exact lot or batch supplied to the laboratory. Depending on the supplier and testing laboratory, documentation may include:

  • Batch or lot number
  • HPLC purity result
  • Mass-spectrometry identity result
  • Testing date
  • Analytical methodology
  • Testing laboratory information

Batch-specific documentation makes it easier for researchers to connect analytical results with the material used in a particular experiment and maintain an appropriate research record.

Storage and Handling

Peptide integrity can be affected by temperature, moisture, light, repeated temperature cycling, and other environmental conditions. Lyophilized research peptides are generally easier to store than peptides maintained continuously in solution, but researchers should still follow the storage specifications provided with the individual batch.

For additional information, see our guide to How to Store Research Peptides.

KPV vs BPC-157: What's the Difference?

KPV and BPC-157 are sometimes grouped together because both appear in discussions of inflammatory and tissue-related research. However, they are very different peptides with substantially different research profiles.

Characteristic KPV BPC-157
Length 3 amino acids 15 amino acids
Origin C-terminal sequence of α-MSH Synthetic pentadecapeptide associated with body-protective-compound research
Primary Research Areas Inflammatory signaling, epithelial and gastrointestinal biology Tissue, vascular, gastrointestinal and musculoskeletal research
Mechanistic Research NF-κB signaling, inflammatory pathways, PepT1 transport Nitric oxide signaling, angiogenesis and tissue-related pathways
Evidence Base Predominantly preclinical Predominantly preclinical

The distinction is therefore primarily one of research mechanism. KPV is particularly interesting for studies focused on inflammatory and epithelial signaling, while BPC-157 has a broader preclinical literature involving vascular, connective-tissue, gastrointestinal, and musculoskeletal models.

Researchers interested in the broader recovery literature can also read our Best Peptides for Recovery Research guide.

Frequently Asked Questions

What is KPV?

KPV is a three-amino-acid peptide consisting of lysine, proline, and valine. It represents the C-terminal sequence of α-MSH and has been investigated primarily in preclinical research involving inflammatory signaling, epithelial biology, gastrointestinal research, and cellular pathways.

What does KPV stand for?

KPV represents the three amino acids in its sequence: K for lysine, P for proline, and V for valine. Its sequence is Lys-Pro-Val.

Is KPV derived from α-MSH?

Yes. KPV is the C-terminal tripeptide sequence of α-MSH. Researchers have studied KPV independently to investigate whether biological activity associated with α-MSH can be attributed to this shorter sequence.

How does KPV work?

The precise mechanism remains under investigation. Research has examined KPV's effects on NF-κB signaling and inflammatory mediator production, as well as its uptake into intestinal epithelial cells through the peptide transporter PepT1. These mechanisms remain subjects of preclinical investigation.

What is KPV studied for?

KPV is primarily studied in inflammatory signaling, epithelial biology, gastrointestinal research, α-MSH-derived peptide research, and cellular signaling. Much of the evidence comes from laboratory and animal models.

Is KPV the same as α-MSH?

No. KPV is only three amino acids long and represents the C-terminal sequence of the much larger α-MSH peptide. Although KPV is derived from α-MSH, it does not have the complete sequence of the parent peptide and has a distinct research profile.

Is KPV the same as BPC-157?

No. KPV and BPC-157 are chemically different peptides with different research profiles. KPV is a three-amino-acid α-MSH-derived peptide, while BPC-157 is a 15-amino-acid synthetic peptide investigated across a broader range of tissue and vascular models.

Is KPV approved for human use?

KPV sold through research-peptide suppliers should be treated as a research material rather than an approved human therapy. The existing literature is predominantly preclinical, and there is insufficient clinical evidence to establish KPV as safe or effective for treating a medical condition in humans.

What are the main areas of KPV research?

The major research areas include inflammatory signaling, NF-κB pathway research, epithelial biology, gastrointestinal research, peptide transport, and α-MSH-derived peptide biology. KPV has also been investigated in experimental models involving cellular inflammatory responses.

Why is KPV studied in gastrointestinal research?

One reason is the presence of peptide transporter 1 (PepT1) in intestinal epithelial cells. Research has investigated whether KPV can be transported through PepT1 and subsequently influence intracellular inflammatory signaling. This provides a useful experimental model for studying interactions between peptide transport and epithelial biology. View the relevant PubMed research.

Does KPV activate melanocortin receptors?

KPV does not contain the complete sequence associated with classical melanocortin receptor activation. Research has therefore focused on alternative mechanisms that may explain KPV's biological activity, including NF-κB-related signaling and PepT1-mediated uptake. The precise mechanism remains an area of investigation.

What should researchers look for when purchasing KPV?

Researchers should look for batch-specific analytical documentation, including HPLC purity testing and mass-spectrometry identity confirmation where applicable. A Certificate of Analysis should correspond to the specific batch supplied, allowing the analytical results to be connected to the material used in an experiment.

Where can researchers buy KPV?

Reta Labs supplies KPV 10mg as a research material for laboratory and scientific applications. The product is supplied as a lyophilized peptide and is intended strictly for research use.

Conclusion: What Is KPV?

KPV is a remarkably small peptide with a disproportionately interesting research history. Consisting of only three amino acids—lysine, proline, and valine—it represents the C-terminal sequence of α-MSH and has been investigated independently for its potential role in inflammatory and cellular signaling.

The most important area of KPV research involves its relationship with inflammatory pathways. Studies have investigated NF-κB signaling, inflammatory mediator production, and the interaction between KPV and epithelial cells. Research involving intestinal PepT1 provides another particularly interesting mechanism, demonstrating how a small peptide can interact with a cellular peptide transporter and potentially influence downstream signaling. Review foundational KPV research on PubMed.

At the same time, the evidence needs to be placed in the correct context. Most KPV research remains cellular or preclinical, and the available human evidence is insufficient to establish clinical safety or efficacy. Experimental observations should therefore be treated as research findings rather than established therapeutic outcomes.

For researchers, KPV's value lies in its simplicity and its connection to a well-characterized biological peptide. It provides a compact model for investigating relationships between peptide sequence, inflammatory signaling, epithelial biology, and cellular transport.

Key Takeaways
  • KPV is a tripeptide composed of lysine, proline, and valine.
  • It represents the C-terminal sequence of α-MSH.
  • KPV has been investigated primarily in inflammatory, epithelial, and gastrointestinal research.
  • Research has examined NF-κB-related inflammatory signaling.
  • Studies have also investigated PepT1-mediated uptake of KPV in intestinal epithelial cells.
  • KPV is distinct from α-MSH despite being derived from its C-terminal sequence.
  • KPV and BPC-157 are different peptides with substantially different research profiles.
  • The current evidence base is predominantly preclinical rather than clinical.

Related Research

If you're researching KPV and related peptide biology, these resources provide additional context:

References & Further Reading

The following peer-reviewed and scientific resources provide additional information about KPV, α-MSH-derived peptides, inflammatory signaling, and peptide transport:

Research Disclaimer

For research use only. This article is provided for educational and scientific research purposes and summarizes findings reported in published literature. KPV is not presented as a treatment, cure, or prevention for any disease or medical condition. Products sold by Reta Labs are intended exclusively for laboratory research and are not intended for human or veterinary use. Nothing in this article should be interpreted as medical advice or as evidence of human safety, efficacy, dosage, or therapeutic benefit.

Back to blog